The Genome Valley region has played a pivotal role in fostering the life science industry and the state government has always supported its growth
It meets stringent requirements for ensuring the safe storage and efficacy of temperature-sensitive vaccines, including those for Covid-19
Decisions reaffirm the ability of Biocon Biologics and Viatris to provide patient access to interchangeable Semglee
While industry steps out of its comfort zone to innovate, the government has to support by allocating funds across research lifecycle and offer incentives for innovation
Branded and unbranded versions of the first-ever interchangeable biosimilar in the U.S. provide more affordable options for the millions of Americans living with diabetes
Aster DM Healthcare announced its financial results for the quarter ended September 30, 2021
Biocon Biologics and Viatris co-developed the products
FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year
Second interchangeable biosimilar product approved by agency
The company plans to launch its exclusive e-pharmacy and telemedicine services in India by December 2021
Subscribe To Our Newsletter & Stay Updated
